Last reviewed · How we verify
NCT00663780
Pharmacogenomic Analysis of Blood Samples to Identify Polymorphisms That Segregate Responders From Non-Responders Following Treatment With Juvidex of Split Skin Donor Sites in Renovo's Clinical Study RN1004-0082
trial in Wound in 195 participants. Completed in 1 September 2008.
1 September 2008
Quick facts
| Lead sponsor | Renovo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 195 |
| Start date | 1 February 2008 |
| Primary completion | 1 September 2008 |
| Estimated completion | 1 September 2008 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Wound — all drugs for Wound →
Sponsor
Renovo — full company profile →
Who can join
Adults 18 to 85, any sex, with Wound. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
To identify polymorphisms that segregate responders from non-responders in respect of response to Juvidex in the clinical trial RN1004-0082
Time frame: Single blood sample
Sponsor's own description
The objective of the study is to identify variations in subjects genetic makeup that segregate responders from non-responders in respect of response to Juvidex in the clinical trial RN1004-0082
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00663780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wound
Currently open trials in the same condition.
- NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
- NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
- NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
- NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00663780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Renovo
- Last refreshed: 5 January 2009
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00663780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing